{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:55:55Z","timestamp":1793660155777,"version":"4.5.1"},"reference-count":21,"publisher":"Japanese Society of Internal Medicine","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,9,1]]},"DOI":"10.2169\/internalmedicine.4958-24","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T17:12:21Z","timestamp":1741367541000},"page":"2597-2603","source":"Crossref","is-referenced-by-count":4,"title":["Two Cases of Tumor-induced Osteomalacia Resulting in Surgical Resection during Burosumab Therapy"],"prefix":"10.2169","volume":"64","author":[{"given":"Dai","family":"Nagata","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Diabetes, Fukuoka University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Takashi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes, Fukuoka University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayuko","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes, Fukuoka University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Toyokawa","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes, Fukuoka University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Makihata","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes, Fukuoka University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruki","family":"Koganemaru","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes, Fukuoka University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saki","family":"Hideshima","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes, Fukuoka University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimi","family":"Muta","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes, Fukuoka University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Yokomizo","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes, Fukuoka University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Fukumoto","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Fukuoka University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizuhide","family":"Nakayama","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Fukuoka University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Muta","sequence":"additional","affiliation":[{"name":"Department of Pathology, Fukuoka University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikiko","family":"Aoki","sequence":"additional","affiliation":[{"name":"Department of Pathology, Fukuoka University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Fukuoka University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuaki","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Fukuoka University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Hamasaki","sequence":"additional","affiliation":[{"name":"Department of Pathology, Fukuoka University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiji","family":"Kawanami","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes, Fukuoka University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Minisola S, Peacock M, Fukumoto S, et al. Tumour-induced osteomalacia. Nat Rev Dis Primers 3: 17044, 2017.","DOI":"10.1038\/nrdp.2017.44"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Folpe AL, Fanburg-Smith JC, Billings SD, et al. Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. Am J Surg Pathol 28: 1-30, 2004.","DOI":"10.1097\/00000478-200401000-00001"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Yamazaki Y, Okazaki R, Shibata M, et al. Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets\/osteomalacia. J Clin Endocrinol Metab 87: 4957-4960, 2002.","DOI":"10.1210\/jc.2002-021105"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Florenzano P, Hartley IR, Jimenez M, Roszko K, Gafni RI, Collins MT. Tumor-induced osteomalacia. Calcif Tissue Int 108: 128-142, 2021.","DOI":"10.1007\/s00223-020-00691-6"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Chong WH, Andreopoulou P, Chen CC, et al. Tumor localization and biochemical response to cure in tumor-induced osteomalacia. J Bone Miner Res 28: 1386-1398, 2013.","DOI":"10.1002\/jbmr.1881"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Minisola S, Fukumoto S, Xia W, et al. Tumor-induced osteomalacia: a comprehensive review. Endocr Rev 44: 323-353, 2023.","DOI":"10.1210\/endrev\/bnac026"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Florenzano P, Gafni RI, Collins MT. Tumor-induced osteomalacia. Bone Rep 7: 90-97, 2017.","DOI":"10.1016\/j.bonr.2017.09.002"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Lamb YN. Burosumab: first global approval. Drugs 78: 707-714, 2018.","DOI":"10.1007\/s40265-018-0905-7"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Imanishi Y, Ito N, Rhee Y, et al. Interim analysis of a phase 2 open-label trial assessing burosumab efficacy and safety in patients with tumor-induced osteomalacia. J Bone Miner Res 36: 262-270, 2021.","DOI":"10.1002\/jbmr.4184"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Jan de Beur SM, Miller PD, Weber TJ, et al. Burosumab for the treatment of tumor-induced osteomalacia. J Bone Miner Res 36: 627-635, 2021.","DOI":"10.1002\/jbmr.4233"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ito N, Shimizu Y, Suzuki H, et al. Clinical utility of systemic venous sampling of FGF23 for identifying tumours responsible for tumour-induced osteomalacia. J Intern Med 268: 390-394, 2010.","DOI":"10.1111\/j.1365-2796.2010.02262.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Andreopoulou P, Dumitrescu CE, Kelly MH, et al. Selective venous catheterization for the localization of phosphaturic mesenchymal tumors. J Bone Miner Res 26: 1295-1302, 2011.","DOI":"10.1002\/jbmr.316"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Piketty ML, Brabant S, Souberbielle JC, et al. FGF23 measurement in burosumab-treated patients: an emerging treatment may induce a new analytical interference. Clin Chem Lab Med 58: e267-e269, 2020.","DOI":"10.1515\/cclm-2020-0460"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Jiang Y, Xia WB, Xing XP, et al. Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: report of 39 cases and review of the literature. J Bone Miner Res 27: 1967-1975, 2012.","DOI":"10.1002\/jbmr.1642"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Takashi Y, Kinoshita Y, Ito N, et al. Tumor-induced osteomalacia caused by a parotid tumor. Intern Med 56: 535-539, 2017.","DOI":"10.2169\/internalmedicine.56.7565"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Ito N, Fukumoto S, Takeuchi Y, et al. Comparison of two assays for fibroblast growth factor (FGF)-23. J Bone Miner Metab 23: 435-440, 2005.","DOI":"10.1007\/s00774-005-0625-4"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Ashrafzadeh-Kian SL, Ito N, Srivastava T, et al. The effect of burosumab on intact and C-terminal FGF23 measurements. Clin Endocrinol (Oxf) 99: 152-157, 2023.","DOI":"10.1111\/cen.14832"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Lyseng-Williamson KA. Burosumab in X-linked hypophosphatemia: a profile of its use in the USA. Drugs Ther Perspect 34: 497-506, 2018.","DOI":"10.1007\/s40267-018-0560-9"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Zhang X, Imel EA, Ruppe MD, et al. Pharmacokinetics and pharmacodynamics of a human monoclonal anti-FGF23 antibody (KRN23) in the first multiple ascending-dose trial treating adults with X-linked hypophosphatemia. J Clin Pharmacol 56: 176-185, 2016.","DOI":"10.1002\/jcph.570"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Sun ZJ, Jin J, Qiu GX, Gao P, Liu Y. Surgical treatment of tumor-induced osteomalacia: a retrospective review of 40 cases with extremity tumors. BMC Musculoskelet Disord 16: 43, 2015.","DOI":"10.1186\/s12891-015-0496-3"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Honda R, Kawabata Y, Ito S, Kikuchi F. Phosphaturic mesenchymal tumor, mixed connective tissue type, non-phosphaturic variant: report of a case and review of 32 cases from the Japanese published work. J Dermatol 41: 845-849, 2014.","DOI":"10.1111\/1346-8138.12602"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/17\/64_4958-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T03:25:29Z","timestamp":1757129129000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/17\/64_4958-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":21,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4958-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"article-number":"4958-24"}}